Obesity: Liraglutide--another weapon in the war against obesity?
作者： George A. Bray
关键词: Liraglutide 、 Drug 、 Pharmacology 、 Glucagon-like peptide-1 、 Medicine 、 Agonist 、 Weight loss 、 Glucose control 、 Endocrinology 、 Type 2 diabetes 、 Obesity 、 Internal medicine
摘要: Liraglutide is an agonist of glucagon-like receptor-1, which a component important biological system that inhibits food intake and enhances insulin secretion from the pancreas in presence glucose. This drug can therefore facilitate weight loss glucose control at same time.
nature.com
sci-hub.se 参考文章(10)
Wilding JP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, SCALE Obesity and Prediabetes NN8022-1839 Study Group., None, A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management The New England Journal of Medicine. ,vol. 373, pp. 11- 22 ,(2015) , 10.1056/NEJMOA1411892
Craig A Johnston, Jennette P Moreno, John P Foreyt, Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England Journal of Medicine. ,vol. 369, pp. 145- 154 ,(2013) , 10.1056/NEJMOA1212914
R Sturm, A Hattori, Morbid obesity rates continue to rise rapidly in the United States International Journal of Obesity. ,vol. 37, pp. 889- 891 ,(2013) , 10.1038/IJO.2012.159
Renee A. Vogt, Gary D. Foster, Gail Brewer, Thomas A. Wadden, What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes. Journal of Consulting and Clinical Psychology. ,vol. 65, pp. 79- 85 ,(1997) , 10.1037//0022-006X.65.1.79
George A. Bray, Evaluation of Drugs for Treating Obesity Obesity Research. ,vol. 3, ,(1995) , 10.1002/J.1550-8528.1995.TB00209.X
Denise G. Simons-Morton, Obesity Research—Limitations of Methods, Measurements, and Medications JAMA. ,vol. 295, pp. 826- 828 ,(2006) , 10.1001/JAMA.295.7.826
Richard F Hamman, Rena R Wing, Sharon L Edelstein, John M Lachin, George A Bray, Linda Delahanty, Mary Hoskin, Andrea M Kriska, Elizabeth J Mayer-Davis, Xavier Pi-Sunyer, Judith Regensteiner, Beth Venditti, Judith Wylie-Rosett, Diabetes Prevention Program Research Group, None, Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes Diabetes Care. ,vol. 29, pp. 2102- 2107 ,(2006) , 10.2337/DC06-0560
Michael D. Jensen, Donna H. Ryan, Caroline M. Apovian, Jamy D. Ard, Anthony G. Comuzzie, Karen A. Donato, Frank B. Hu, Van S. Hubbard, John M. Jakicic, Robert F. Kushner, Catherine M. Loria, Barbara E. Millen, Cathy A. Nonas, F. Xavier Pi-Sunyer, June Stevens, Victor J. Stevens, Thomas A. Wadden, Bruce M. Wolfe, Susan Z. Yanovski, 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults Journal of the American College of Cardiology. ,vol. 63, pp. 2985- 3023 ,(2014) , 10.1016/J.JACC.2013.11.004
Priya Sumithran, Luke A. Prendergast, Elizabeth Delbridge, Katrina Purcell, Arthur Shulkes, Adamandia Kriketos, Joseph Proietto, Long-Term Persistence of Hormonal Adaptations to Weight Loss The New England Journal of Medicine. ,vol. 365, pp. 1597- 1604 ,(2011) , 10.1056/NEJMOA1105816
Danny S. Parker, The Battle of the Bulge ,(1991)